Use of Indirect Calorimetry in Obesity

July 27, 2017 updated by: Anna Ferrulli, Ospedale San Donato

Use of Indirect Calorimetry in Dietary Setting in Obese Subjects: Retrospective Observational Study

The investigators will retrospectively analyze and compare data of 2 groups of overweight and obese patients: subjects who followed a diet based on Resting Energy Expenditure (REE) measured by indirect calorimetry and subjects who followed a diet based on REE estimated by the Harris-Benedict equation. Propensity score adjustment will be used to adjust for known differences between the 2 groups

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

355

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • MI
      • San Donato Milanese, MI, Italy, 20097
        • San Donato Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 86 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

To collect clinical data of a total population comprising patients referred to our Endocrinology-Diabetes Outpatient Clinic, in the period from April 2012 through October 2016.

In this retrospective study, will be considered patients with an age ranging from 20 to 86 years, with overweight (25 ≤ BMI ≤ 29.9) or obesity (BMI ≥ 30), requiring dietary intervention for weight control.

Statistical analysis will perform on overweight and obese patients divided into two subgroups: IC group and NO-IC group.

Anthropometric status and metabolic biomarkers will re-evaluated at check-ups performed after 3 months, 6 months, 12 months and 18 months from the baseline.

Description

Inclusion Criteria:

  • BMI >25
  • Age ranging from 20 to 86 years

Exclusion Criteria:

  • BMI<25
  • Age <20
  • Age >86

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Indirect Calorimetry group (IC group)
Group who performed indirect calorimetry. REE measured by indirect calorimetry.

Indirect calorimetry will be performed by using an open-circuit calorimeter (Sensor Medics, Italy). Indirect calorimetry is the reference method for energy expenditure determination. A canopy hood covered the patient's head and expired air is extracted by a pump to be analyzed by metabolic cart sensors; flow rate is directly measured with a digital turbine flowmeter. After an overnight fast, patients will asked to lay supine in complete physical rest, not sleeping or talking for approximately 20-25 minutes, at a room temperature ranged between 22 and 24°C. The mean REE for each participant considers the last 15-20 minutes of measurements corresponding to steady state.

Software of calorimeter will be set for minute-by-minute reading report of VO2 (Oxygen flow) and VCO2 (Carbon dioxide flow) measurement.

Parameters obtained by Indirect Calorimetry will be the Resting Energy Expenditure and the Respiratory Quotient (RQ)

NO Indirect Calorimetry group (NO-IC group)
Group who did not perform indirect calorimetry. Resting Energy Expenditure calculated by Harris-Benedict formula

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight in Indirect Calorimetry group and in NO Indirect Calorimetry group
Time Frame: 18 months
To compare body weight variation (kg) in two groups of overweight or obese patients: subjects who followed a diet formulated on REE measured by IC (IC group) and subjects who followed a diet based on REE predicted by the Harris-Benedict formula (NO-IC group)
18 months
BMI in Indirect Calorimetry group and in NO Indirect Calorimetry
Time Frame: 18 months
To compare BMI variation (kg/m^2) in two groups of overweight or obese patients: subjects who followed a diet formulated on REE measured by IC (IC group) and subjects who followed a diet based on REE predicted by the Harris-Benedict formula (NO-IC group)
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight in male/female in Indirect Calorimetry group and in NO indirect Calorimetry group
Time Frame: 18 months
To identify gender differences in weight variation (kg) between IC and NO-IC groups
18 months
BMI in male/female in Indirect Calorimetry group and in NO indirect
Time Frame: 18 months
To identify gender differences in BMI variation (kg/m^2) between IC and NO-IC groups
18 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight in adequate to predicted REE and in NOT adequate to predicted REE subpopulations
Time Frame: 18 months
to compare body weight variation (kg) in two sub-populations of the IC-group: subjects with adequate to predicted REE and subjects with not adequate to predicted REE
18 months
BMI in adequate to predicted REE and in NOT adequate to predicted REE subpopulations
Time Frame: 18 months
to compare BMI variation in two sub-populations of the IC-group: subjects with adequate to predicted REE and subjects with not adequate to predicted REE
18 months
Weight in subjects with RQ<0.9 and subjects with RQ>0.9
Time Frame: 18 months
to compare body weight variation in 2 subpopulation of the IC group: subjects with an RQ ≤ 0.9 and subjects with RQ > 0.9.
18 months
BMI in subjects with RQ<0.9 and subjects with RQ>0.9
Time Frame: 18 months
BMI variation in 2 subpopulation of the IC group: subjects with an RQ ≤ 0.9 and subjects with RQ > 0.9.
18 months
Glucose in Indirect Calorimetry group and in NO Indirect Calorimetry Group
Time Frame: 18 months
to identify differences in glucose (mg/dl) variation between IC and NO-IC groups
18 months
Tryglycerides in Indirect Calorimetry group and in NO Indirect Calorimetry Group
Time Frame: 18 months
to identify differences in tryglycerides (mg/dl) variation between IC and NO-IC groups
18 months
Total cholesterol (mg/dl) in Indirect Calorimetry group and in NO Indirect Calorimetry Group
Time Frame: 18 months
to identify differences in cholesterol variation between IC and NO-IC groups
18 months
Hemoglobin in Indirect Calorimetry group and in NO Indirect Calorimetry Group
Time Frame: 18 months
to identify differences in glycated hemoglobin (%) variation between IC and NO-IC groups
18 months
Uric acid in Indirect Calorimetry group and in NO Indirect Calorimetry Group
Time Frame: 18 months
to identify differences in uric acid (mg/dl) variation between IC and NO-IC groups
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Livio Luzi, Professor, IRCCS Policlinico San Donato

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2012

Primary Completion (Actual)

October 31, 2016

Study Completion (Actual)

October 31, 2016

Study Registration Dates

First Submitted

July 21, 2017

First Submitted That Met QC Criteria

July 27, 2017

First Posted (Actual)

July 28, 2017

Study Record Updates

Last Update Posted (Actual)

July 28, 2017

Last Update Submitted That Met QC Criteria

July 27, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • CALO/Obesity

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Indirect calorimetry

3
Subscribe